**6. References**


Diagnosis and Treatment of Primary Aldosteronism 133

[20] Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular

[21] Davis WW, Newsome Jr HH, Wright Jr LD, Hammond WG, Easton J, Bartter FC.

[22] Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf).

[23] Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primaryaldosteronism,

[24] Kaplan NM. Is there an unrecognized epidemic of primary aldosteronism? Pro.

[25] Stowasser M, Gordon RD, Rutheford JC, et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001;2:156–69. [26] Mulatero P, Rabbia F, Milan A, et al. Drug effects on aldosterone/plasma renin activity

[27] Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. *J Clin Endocrinol Metab.* 2006;91(7):2618-2623. [28] Castro OL, Yu X, Kem DC. Diagnostic value of the post-captopril test in primary

[29] Young WF Jr. Minireview: Primary Aldosteronism—changing concepts in diagnosis

[30] Young Jr WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med

[31] Mulatero P, Bertello C, Verhovez A, et al. Differential diagnosis of primary

[32] Rossi, G. P., Vendraminelli, R., Cesari, M. and Pessina, A. C. A thoracic mass with

[33] Omura, M., Sasano, H., Fujiwara, T., Yamaguchi, K. & Nishikawa, T. Unique cases of

[34] Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein samplingand computed

[35] Goh, B. K. *et al.* Primary hyperaldosteronism secondary to unilateral adrenal

[36] Daunt, N. Adrenal vein sampling: how to make it quick, easy, and successful.

unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. *Metabolism* 

tomography in the differentiation of primary aldosteronism. *J Clin Endocrinol* 

hyperplasia: an unusual cause of surgically correctable hypertension. A review of

aldosteronism subtypes. Curr Hypertens Rep. 2009;11:217–23.

hypertension and hypokalaemia. *Lancet* 2000; 356, 1570.

ratio in primary aldosteronism. *Hypertension.* 2002;40(6): 897-902.

2008;168:80–5.

2007;66:607–18.

2007;356:601–610

2002;51, 350–355.

*Metab.* 2001;86(3):1066-1071

30 cases. *World J. Surg.2007;*31, 72–79.

*Radiographics* 2005; 25 (Suppl. 1), S143–S158.

*Endocrinol Metab.* 2004;89(3):1045-1050.

aldosteronism. *Hypertension.* 2002;39(4):935-938.

and treatment. *Endocrinology.* 2003;144(6):2208-2213.

*Hypertension.* 2007;50(3):447-453.

7.

outcomes in patients with primary aldosteronism after treatment. Arch Intern Med.

Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity. Am J Med. 1967;42:642–

including surgically correctable forms, in centers from fi ve continents. *J Clin* 


[5] Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and

[6] Mosso L, Carvajal C, González A, et al. Primary aldosteronism and hypertensive disease.

[7] Rossi, G. P. *et al.* A prospective study of the prevalence of primary aldosteronism in 1,125

[8] Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control

[9] Rocha R, Stier Jr CT. Pathophysiological effects of aldosterone inncardiovascular tissues.

[10] Tsioufis C, Tsiachris D, Dimitriadis K, Stougiannos P, Missovoulos P, Kakkavas A, et al.

[11] Brilla CG, Weber KT. Reactive and reparative myocardial fibrosis in arterial

[12] Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A. The effect of spironolactone on

[13] Williams ES, Miller JM. Results from late-breaking clinical trial sessions at the American

[14] Brown NJ, Agrbasli MA, Williams GH, Litchfield WR, Vaughan DE. Effect of activation

[15] Struthers AD. Aldosterone escape during ACE inhibitor therapy in chronic heart

[16] Tiryaki O, Usalan C, Buyukhatipoglu H. Effect of combined angiotensin-converting

[17] Rossi, G. P., Pessina, A. C. And Heagerty, A. M. Primary aldosteronism: an update on

[18] Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, et al.

[19] Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased

screening, diagnosis and treatment. *J. Hypertens.* 2008;26, 613–621.

hypertensive patients. *J. Am. Coll. Cardiol.* 2006;48: 2293–2300 .

2008;117(25):e510-e526.

2002;4:393-404.

341: 709–17.

1–18.

211-5.

Cardiol. 2008;31:431–6.

*Hypertension* 1998; 32: 965–71.

failure. *Eur. Heart J.* 1995; 16: 103–6.,

Clin Endocrinol Metab. 2009;94:1125–30.

Cardiol. 2005;45:1243–8.

*Hypertension.* 2003;42(2):161-165.

Trends Endocrinol Metab. 2001;12:308–14.

hypertension in the rat. Cardiovasc Res. 1992;26:671–7.

treatment: a scientifi c statement from the american heart association professional education committee of the Council for High Blood Pressure Research. *Circulation.* 

in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich).

Myocardial and aortic stiffening in the early course of primary aldosteronism. Clin

morbidity and mortality in patients with severe heart failure. *N. Engl. J. Med.* 1999;

College of Cardiology 51st Annual Scientific Session. *J. Am. Coll. Cardiol.* 2002; 40:

and inhibition of the rennin angiotensin system on plasma PAI-1 in humans.

enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients. Nephrology (Carlton), 2010;15(2):

Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J

rate of cardiovascular events in patients with primary aldosteronism. J Am Coll


[37] Takeda Y, Yoneda T, Karashima S, Demura M, Hashimoto A, Mori S, et al. Rapid assay

[38] Jeschke, K. *et al.* Laparoscopic partial adrenalectomy in patients with aldosterone-

[39] Meria, P., Kempf, B. F., Hermieu, J. F., Plouin, P. F. & Duclos, J. M. Laparoscopic

[40] Sawka, A. M. *et al.* Primary aldosteronism: factors associated with normalization of

[41] Lumachi, F. *et al.* Long-term results of adrenalectomy in patients with aldosterone-

[43] Sukor N, Gordon RD, Ku YK, et al. Role of unilateral adrenalectomy in bilateral

hypertension and review of the literature. *Am. Surg.*2005; 71, 864–869. [42] Sukor N, Kogovsek C, Gordon RD, et al. Improved quality of life, blood pressure, and

blood pressure after surgery. *Ann. Intern. Med.* 2001;135, 258–261.

aldosteronism. J Clin Endocrinol Metab. 2010;95:1360–4.

aldosteronism. J Hypertens. 2009;27 Suppl 4:S446.

72.

*Urol.* 2003;169, 32–35.

2009;94:2437–45.

of cortisol during adrenal vein sampling is useful for the diagnosis of primary

producing adenomas: indications, technique, and results. *Urology* 2003;61, 69–

management of primary hyperaldosteronism: clinical experience with 212 cases. *J.* 

producing adenomas: multivariate analysis of factors affecting unresolved

biochemical status following laparoscopic adrenalectomy for unilateral primary

primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab.
